Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age. (CETC)
Sponsor: Labor Prof. Pachmann
A observational or N/A phase clinical study on Tumor Cell, Circulating, this trial is actively recruiting participants. The trial is conducted by Labor Prof. Pachmann and has accumulated 8 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
-
Dec 2022 — Dec 2023 [monthly]
Recruiting
-
Dec 2021 — Dec 2022 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Nov 2021 — Dec 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Nov 2021 [monthly]
Not Yet Recruiting
-
Jun 2021 — Sep 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Labor Prof. Pachmann
- University Hospital Erlangen
- University of Jena
For direct contact, visit the study record on ClinicalTrials.gov .